In a recent SEC filing, Casdin Partners Master Fund, L.P. reported a significant acquisition of shares in Standard BioTools Inc. (NASDAQ: LAB). On February 28, the fund acquired approximately 4.82 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results